BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 19435643)

  • 21. Feasibility of high-dose three-dimensional radiation therapy in the treatment of localised non-small-cell lung cancer.
    Bellière A; Girard N; Chapet O; Khodri M; Kubas A; Souquet PJ; Mornex F
    Cancer Radiother; 2009 Jul; 13(4):298-304. PubMed ID: 19525134
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancer.
    Haddad R; Sonis S; Posner M; Wirth L; Costello R; Braschayko P; Allen A; Mahadevan A; Flynn J; Burke E; Li Y; Tishler RB
    Cancer; 2009 Oct; 115(19):4514-23. PubMed ID: 19634161
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Administration of S-1 after gastrojejunostomy for unresectable gastric cancer with pyloric stenosis].
    Nishikawa K; Iwase K; Fujii M; Matsuda C; Shimada K; Hirota M; Kimura T; Wada D; Nasu S; Tanaka Y
    Gan To Kagaku Ryoho; 2009 Apr; 36(4):595-8. PubMed ID: 19381030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical investigation of weekly Carboplatin and Paclitaxel with concurrent radiation therapy for locally advanced non-small cell lung cancer].
    Mito A; Yamasaki M; Matsuura K; Kajihara T; Nitta T; Awaya H; Arita K; Kashiwado K; Ohashi N
    Gan To Kagaku Ryoho; 2009 Oct; 36(10):1653-6. PubMed ID: 19838022
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contrasting effects of extended low dose versus standard dose shorter course UFT chemotherapy on microscopic versus macroscopic established tumors: implications for optimal postoperative adjuvant chemotherapy.
    Uchida J; Okabe H; Nakano K; Fujioka A; Saito H; Sugimoto Y; Oka T; Fukushima M
    Oncol Rep; 2007 Aug; 18(2):313-9. PubMed ID: 17611650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neoadjuvant 5 fluorouracil-cisplatin chemoradiation effect on survival in patients with resectable pancreatic head adenocarcinoma: a ten-year single institution experience.
    Turrini O; Viret F; Moureau-Zabotto L; Guiramand J; Moutardier V; Lelong B; de Chaisemartin C; Giovannini M; Delpero JR
    Oncology; 2009; 76(6):413-9. PubMed ID: 19407474
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Consecutive re-explorations for final resection of initially unresectable pancreatic head carcinoma.
    Lygidakis NJ; Vlachos L; Raptis S; Sgourakis G; Mourikis D; Kehagias D
    Hepatogastroenterology; 1999; 46(28):2229-39. PubMed ID: 10521972
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of patients with unresectable advanced carcinoma of biliary tract - chemotherapy and surgical resection.
    Morise Z; Sugioka A; Tanahashi Y; Okabe Y; Ikeda M; Kagawa T; Takeura C
    Anticancer Res; 2009 May; 29(5):1783-6. PubMed ID: 19443404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retrospective review of surgery and definitive chemoradiotherapy in patients with squamous cell carcinoma of the thoracic esophagus aged 75 years or older.
    Kosugi S; Sasamoto R; Kanda T; Matsuki A; Hatakeyama K
    Jpn J Clin Oncol; 2009 Jun; 39(6):360-6. PubMed ID: 19389794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of concurrent chemoradiotherapy for T1 and T2 laryngeal squamous cell carcinoma regarding organ preservation.
    Nishimura G; Tsukuda M; Mikami Y; Matsuda H; Horiuchi C; Taguchi T; Takahashi M; Kawakami M; Watanabe M; Niho T; Abo H; Yamomoto S
    Anticancer Res; 2009 Feb; 29(2):661-6. PubMed ID: 19331217
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic factors for survival and resection in patients with initial nonresectable locally advanced pancreatic cancer treated with chemoradiotherapy.
    Bjerregaard JK; Mortensen MB; Jensen HA; Nielsen M; Pfeiffer P
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):909-15. PubMed ID: 22172900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The efficacy of S-1 monotherapy as a 2nd/3rd-line therapy for unresectable recurrent colon cancer: Kanagawa conference of clinical oncology (KCCO)].
    Yokoyama T; Tokuhara H; Egawa T; Hashimoto O; Seki H; Koyanagi K; Bessho T
    Gan To Kagaku Ryoho; 2009 Oct; 36(10):1667-70. PubMed ID: 19838025
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The treatment of locally advanced pancreatic cancer.
    Wagener DJ; de Mulder PH
    Anticancer Res; 1989; 9(4):1009-11. PubMed ID: 2683985
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dihydropyrimidine dehydrogenase activity during long-term adjuvant treatment with oral uracil and tegafur for colorectal cancer.
    Sadahiro S; Suzuki T; Maeda Y; Ishikawa K; Tanaka Y; Yasuda S; Kamijo A; Makuuchi H; Murayama C
    Chemotherapy; 2007; 53(6):442-5. PubMed ID: 17952005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemoradiotherapy for locally advanced pancreatic cancer: a radiotherapy dose escalation and organ motion study.
    Henry AM; Ryder WD; Moore C; Sherlock DJ; Geh JI; Dunn P; Price P
    Clin Oncol (R Coll Radiol); 2008 Sep; 20(7):541-7. PubMed ID: 18562186
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Risk of cardiotoxicity of combination treatment radiotherapy and chemotherapy of locally advanced breast carcinoma stage III].
    Bustová I
    Klin Onkol; 2009; 22(1):17-21. PubMed ID: 19534435
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Review of adjuvant radiochemotherapy for resected pancreatic cancer and results from Mayo Clinic for the 5th JUCTS symposium.
    Miller RC; Iott MJ; Corsini MM
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):364-8. PubMed ID: 19735864
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preoperative chemoradiation combined with regional hyperthermia for patients with resectable esophageal cancer.
    Hulshof MC; Van Haaren PM; Van Lanschot JJ; Richel DJ; Fockens P; Oldenborg S; Geijsen ED; Van Berge Henegouwen MI; Crezee J
    Int J Hyperthermia; 2009 Feb; 25(1):79-85. PubMed ID: 19219704
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Locally advanced pancreatic cancer: current therapeutic approach.
    Cardenes HR; Chiorean EG; Dewitt J; Schmidt M; Loehrer P
    Oncologist; 2006 Jun; 11(6):612-23. PubMed ID: 16794240
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The incidence of perioperative anastomotic complications after sleeve lobectomy is not increased after neoadjuvant chemoradiotherapy.
    Milman S; Kim AW; Warren WH; Liptay MJ; Miller C; Basu S; Faber LP
    Ann Thorac Surg; 2009 Sep; 88(3):945-50; discussion 950-1. PubMed ID: 19699925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.